Assessing the Short- and Long-Term Effects and Causes of Gestational Diabetes

Introduction

Gestational diabetes, scientifically referred to as gestational diabetes mellitus (GDM), is a prevalent medical condition that manifests in women who have not previously exhibited signs of diabetes but demonstrate elevated blood glucose levels during their gestational period. Diabetes mellitus, a metabolic disorder characterized by high blood sugar levels, has been observed to impact approximately 19% of pregnancies. This prevalence is believed to be increasing due to contemporary lifestyles that often involve excessive consumption of sugar, leading to the development of insulin resistance within the body. During pregnancy, regular visits are critical to ensure that the blood sugar is monitored. In addition, a healthy diet and supervised activity could be beneficial to both the baby and the mother. If not well managed, diabetes could be a cause for concern for both the baby and the mother during pregnancy, birth and later in life. In this paper, the aim is to gather more knowledge on why gestational diabetes disappears after birth and whether the child is at significant risk of developing diabetes in the latter stages of their life. This paper will demonstrate that the disappearance of gestational diabetes after childbirth raises concerns vis-à-vis the basic mechanisms through which this form of diabetes is developed and the potential long-term health implications for the mother and the baby regarding developing diabetes.

Maternal Diabetes and Offspring's Adiposity

Effects of Maternal Hyperglycemia on Fetal Growth and Development

Macrosomia (Large Birth Weight)

 This is a condition characterized by an infant's excessive birth weight, associated with high levels of glucose in the mother's bloodstream and, consequently, gestational diabetes. Babies with this condition usually weigh more than 8 pounds and 13 ounces. Large birth weight occurs because the excess glucose available for the baby promotes excessive fetal growth. To this end, Lawlor et al. (2009) conducted research to determine whether there is a significant relationship between high glucose levels and increased birth weight. The authors found a significant correlation between elevated maternal glucose levels following a diabetes diagnosis and increased birth weight in addition to higher concentrations of C-peptide in the serum of the umbilical cord. In support of these findings, Metzger et al. (2008) documented that a rise in the 2-hour plasma glucose level increases the likelihood of a baby being born with a weight exceeding the 90th percentile by 1.38 times. As such, it can be concluded that Lawlor et al. (2009) and Metzger et al. (2008) provide compelling evidence supporting a consistent and strong association between maternal glucose levels below the diagnostic threshold for diabetes and increased birth weight, as well as elevated levels of C-peptide in the cord-blood serum.

To mitigate these risks, one must first confirm the diagnosis. In the literature, there are several fetal tests available to assess fetal activity during mid-pregnancy. First, during the initial 11 weeks of gestation, one can use various diagnostic assessment tools, which include the biophysical profile, nonstress test (NST), and evaluation of arterial-wave-form velocities to ascertain the presence of any potential complications pertaining to fetal development. While it is acknowledged that utilizing certain methodologies is time-intensive, these tools have proven valuable in elucidating issues pertaining to fetal development and facilitating informed decision-making throughout pregnancy. The success of these experiments is primarily attributed to the fetal responses to external stimuli, particularly sound. The following methods can be used to manage and prevent the effects of gestational diabetes on the infant.

First, controlling the blood sugar. One can use a blood sugar testing kit to monitor their blood sugar and follow appropriate treatment plans, preventing adverse outcomes for the mother and the baby (Hedderson et al., 2010). Second, one can modify one's diet and increase supervised physical activity (Hedderson et al., 2010). This helps by controlling blood sugar and reducing excessive weight gain during pregnancy. The key is optimizing one’s caloric intake to one's level of exercise (Hedderson et al., 2010). In addition, medication can be used to manage blood sugar of exercise is insufficient. Two options, i.e., metformin and insulin, have been tested, and their effectiveness is documented by Rowan et al. (2008). According to Rowan et al. (2008), the utilization of metformin as a potential therapeutic approach for women diagnosed with gestational diabetes mellitus appears to be a rational choice.

Rowan et al. (2008) observed that the speed of the primary composite outcome was 32.0% in the group of women assigned to metformin and 32.2% in the insulin group. Further, a majority of women who were administered metformin injections expressed a preference for this treatment over insulin. In addition, 46.3% of these women required supplemental insulin in conjunction with metformin during the course of their treatment. Conversely, the participants expressed a strong inclination towards receiving the identical intervention during their subsequent pregnancies, with a significant difference observed between the two groups (76.6% vs. 27.2%). It is noteworthy that metformin exhibited a favorable safety profile, with no significant occurrence of serious adverse effects. Nevertheless, the comparative analysis of treatment acceptance rates between the two groups, namely those administered metformin and those administered insulin, revealed minimal differences.

Maternal Diabetes and Offspring's Pregnancy Outcomes

Maternal Diabetes and Offspring's Risk of Diabetes

Maternal Diabetes Effect on Offspring’s Immune System and Genetic MakeUp

Maternal diabetes during pregnancy affects the immune system and genetic composition. This happens because exposure to elevated blood sugar levels could affect regulatory mechanisms that govern immune responses. These changes can contribute to an increased risk of autoimmune responses, including those associated with the development of diabetes. In addition, epigenetic modifications, such as DNA methylation and histone acetylation, can be altered by the intrauterine environment shaped by maternal diabetes. This impacts gene expression patterns relevant to glucose metabolism, insulin sensitivity, and the regulation of pancreatic function, ultimately influencing the risk of diabetes in the offspring. Thus, maternal diabetes has the potential to exert an influence on the infant's genetic profile and immune system, affecting their well-being.

According to research by Blotsky et al. (2019), the incidence of pediatric diabetes per ten thousand person-years is higher (4.52) in children born to mothers with gestational diabetes than in the general population (2.4). When all factors are adjusted, Blotsky et al. (2019) establish that maternal gestational diabetes is associated with the development of pediatric diabetes. Another research by Wang et al. (2020) supports these findings and adds that feeding and eating disorders in offspring are also positively associated with being born to a mother with gestational diabetes. Based on the study, the incidence rate for feeding and eating disorders is higher (6.8) per ten thousand person-years in infants born to a mother with gestational diabetes than in the general population (2.9). This directly relates to obesity.

Causes of Gestational Diabetes and Preventive Measures

Causes

Hormonal Fluctuations During Pregnancy

Pregnancy hormones could interfere with insulin, a hormone responsible for regulating the blood sugar level. In this case, the mother's body experiences a deficiency in insulin production. This deficiency is attributed to the body utilizing the available insulin to support pregnancy, resulting in a depletion of insulin levels (Choudhury & Rajeswari, 2021). Consequently, this depletion leads to a condition known as hyperglycemia, characterized by abnormally elevated levels of glucose in the bloodstream. In addition, as established by Retnakaran et al. (2010), women with gestational diabetes have a declining β-cell function in the 1st year postpartum. According to Choudhury and Rajeswari (2021), this leads to hyperglycemia because β-cell assists in balancing the demand for and supply of insulin.

Obesity

Hufnagel, A., Dearden, L., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2022). Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia. Journal of Endocrinology, 253(2), R47–R63. https://doi.org/10.1530/joe-21-0332

Kekki, M., Tihtonen, K., Salonen, A., Koukkula, T., Gissler, M., Laivuori, H., & Huttunen, T. T. (2022). Severe birth injuries in neonates and associated risk factors for injury in mothers with different types of diabetes in Finland. International Journal of Gynecology & Obstetrics, 159(1), 195–203. https://doi.org/10.1002/ijgo.14073

Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B. M., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., Sciscione, A., Catalano, P. M., Harper, M., Saade, G. R., Lain, K., Sorokin, Y., Peaceman, A. M., Tolosa, J. E., & Anderson, G. (2009). A multicenter, randomized trial of treatment for mild gestational diabetes. The New England Journal of Medicine, 361(14), 1339–1348. https://doi.org/10.1056/nejmoa0902430

Lawlor, D. A., Fraser, A., Lindsay, R., Ness, A. R., Dabelea, D., Catalano, P. M., Smith, G. D., Sattar, N., & Nelson, S. M. (2009). Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia, 53(1), 89–97. https://doi.org/10.1007/s00125-009-1560-z

Li, G., Tao, W., Ni, W., Ai, Z., Zhang, J., Xing, Y., & Xing, Q. (2020). Incidence and risk factors of gestational diabetes mellitus: a prospective cohort study in Qingdao, China. Frontiers in Endocrinology, 11. https://doi.org/10.3389/fendo.2020.00636

Metzger, B. E., Lowe, L. P., Dyer, A. R., Trimble, E. R., Chaovarindr, U., Coustan, D. R., Hadden, D. R., McCance, D. R., Hod, M., McIntyre, H. D., Oats, J., Persson, B., Rogers, M. S., & Sacks, D. A. (2008). Hyperglycemia and adverse pregnancy outcomes. The New England Journal of Medicine, 358(19), 1991–2002. https://doi.org/10.1056/nejmoa0707943

Retnakaran, R., Qi, Y., Sermer, M., Connelly, P. W., Hanley, A. J., & Zinman, B. (2010). Β-Cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy. Diabetes Care, 33(8), 1798–1804. https://doi.org/10.2337/dc10-0351

Rowan, J., Hague, W., Gao, W., Battin, M., & Moore, M. C. (2008). Metformin versus Insulin for the Treatment of Gestational Diabetes. The New England Journal of Medicine, 358(19), 2003–2015. https://doi.org/10.1056/nejmoa0707193

Wang, H., He, H., Yu, Y., Su, X., Li, F., & Li, J. (2020). Maternal diabetes and the risk of feeding and eating disorders in offspring: a national population-based cohort study. BMJ Open Diabetes Research & Care, 8(1), e001738. https://doi.org/10.1136/bmjdrc-2020-001738